|
Lex M. Cowsert, PhD, Chief Scientific Officer - Dr. Cowsert has 13 years of biotechnology experience from Vistagen, where he was Vice President of Functional Genomics, and Isis Pharmaceuticals. During his 11 years at Isis, Dr. Cowsert developed and implemented Isis’ Rapid Throughput Screening (RTS) for lead discovery and functional genomics and executed RTS internally and with collaborators. The RTS program grew into the GeneTrove division at Isis. Earlier, Dr. Cowsert took two Isis lead molecules through preclinical and Phase 1 and 2 clinical studies. He has over 120 issued U.S. patents. Dr. Cowsert did his post-doctoral research at the National Cancer Institute, and received his PhD in Microbiology and pathology from Georgetown University Medical School in 1986, and his BS in Zoology from the University of Florida. | 